Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Bimekizumab versus Secukinumab in Plaque PsoriasisThe New England journal of medicine, 2021-07, Vol.385 (2), p.142-152 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2102383 ;PMID: 33891380Full text available |
2 |
Material Type: Article
|
![]() |
Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine HubsThe New England journal of medicine, 2021-08, Vol.385 (7), p.628-639 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMra1909094Full text available |
3 |
Material Type: Article
|
![]() |
CD19-Targeted CAR T Cells in Refractory Systemic Lupus ErythematosusThe New England journal of medicine, 2021-08, Vol.385 (6), p.567-569 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2107725 ;PMID: 34347960Full text available |
4 |
Material Type: Article
|
![]() |
Pulmonary Arterial HypertensionThe New England journal of medicine, 2021-12, Vol.385 (25), p.2361-2376 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMra2000348 ;PMID: 34910865Full text available |
5 |
Material Type: Article
|
![]() |
Bimekizumab versus Adalimumab in Plaque PsoriasisThe New England journal of medicine, 2021-07, Vol.385 (2), p.130-141 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2102388Full text available |
6 |
Material Type: Article
|
![]() |
Nonspecific Low Back PainThe New England journal of medicine, 2022-05, Vol.386 (18), p.1732-1740 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMcp2032396 ;PMID: 35507483Full text available |
7 |
Material Type: Article
|
![]() |
Domains and outcome measures for the assessment of limited cutaneous systemic sclerosis:a scoping review protocolISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2020-044765Full text available |
8 |
Material Type: Article
|
![]() |
Decompression with or without Fusion in Degenerative Lumbar SpondylolisthesisThe New England journal of medicine, 2021-08, Vol.385 (6), p.526-538 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;info:eu-repo/semantics/openAccess ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2100990 ;PMID: 34347953Full text available |
9 |
Material Type: Article
|
![]() |
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus ErythematosusThe New England journal of medicine, 2022-09, Vol.387 (10), p.894-904 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2118025Full text available |
10 |
Material Type: Article
|
![]() |
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus ErythematosusThe New England journal of medicine, 2022-07, Vol.387 (4), p.321-331 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2118024Full text available |
11 |
Material Type: Article
|
![]() |
Trial of Intravenous Immune Globulin in DermatomyositisThe New England journal of medicine, 2022-10, Vol.387 (14), p.1264-1278 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2117912 ;PMID: 36198179Full text available |
12 |
Material Type: Article
|
![]() |
İki Nokta Diskriminasyon Testi Fibromiyaljinin Tanısında Yeni Bir Tanı Yöntemi midir?Noro-Psikiyatri Arsivi, 2022-06, Vol.59 (2), p.87-90 [Peer Reviewed Journal]Copyright BAYT Ltd. Co. Jun 2022 ;ISSN: 1300-0667 ;EISSN: 1309-4866 ;DOI: 10.29399/npa.27245Full text available |
13 |
Material Type: Article
|
![]() |
Neuromyelitis Optica Spectrum DisorderThe New England journal of medicine, 2022-08, Vol.387 (7), p.631-639 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMra1904655Full text available |
14 |
Material Type: Article
|
![]() |
Patient-reported experience with patient-reported outcome measures in adult patients seen in rheumatology clinicsQuality of life research, 2021-04, Vol.30 (4), p.1073-1082 [Peer Reviewed Journal]Springer Nature Switzerland AG 2020 ;COPYRIGHT 2021 Springer ;Springer Nature Switzerland AG 2020. ;ISSN: 0962-9343 ;EISSN: 1573-2649 ;DOI: 10.1007/s11136-020-02692-2 ;PMID: 33170400Full text available |
15 |
Material Type: Article
|
![]() |
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid TaperThe New England journal of medicine, 2023-10, Vol.389 (14), p.1263-1272 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2303452Full text available |
16 |
Material Type: Article
|
![]() |
Systemic sclerosisThe Lancet (British edition), 2017-10, Vol.390 (10103), p.1685-1699 [Peer Reviewed Journal]Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 7, 2017 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)30933-9 ;PMID: 28413064Full text available |
17 |
Material Type: Article
|
![]() |
Chronic UrticariaThe New England journal of medicine, 2022-09, Vol.387 (9), p.824-831 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMra2120166Full text available |
18 |
Material Type: Article
|
![]() |
A Phase 2 Trial of Peresolimab for Adults with Rheumatoid ArthritisThe New England journal of medicine, 2023-05, Vol.388 (20), p.1853-1862 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2209856 ;PMID: 37195941Full text available |
19 |
Material Type: Article
|
![]() |
Phase 2 Trial of Iberdomide in Systemic Lupus ErythematosusThe New England journal of medicine, 2022-03, Vol.386 (11), p.1034-1045 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2106535 ;PMID: 35294813Full text available |
20 |
Material Type: Article
|
![]() |
TOFA-PREDICT study protocol: a stratification trial to determine key immunological factors predicting tofacitinib efficacy and drug-free remission in psoriatic arthritis (PsA)info:eu-repo/semantics/OpenAccess ;ISSN: 2044-6055 ;EISSN: 2044-6055Full text available |